Krystal Biotech (KRYS) Interest & Investment Income (2018 - 2026)
Krystal Biotech (KRYS) reported Interest & Investment Income of -$1.6 million for Q1 2026, down 558.43% on a YoY basis from $344000.0 in Q1 2025, and down 684.58% sequentially from -$201000.0 in Q4 2025.
Krystal Biotech (KRYS) Interest & Investment Income (2018 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 9 years of Interest & Investment Income data on file, last reported at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 558.43% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 264.18% YoY), and the FY2025 full-year result was $642000.0, up 245.91% from the prior year.
- Interest & Investment Income slipped to -$1.6 million in Q1 2026, from -$201000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.8 million in Q3 2024 to a low of -$1.6 million in Q1 2026.
- A 5-year average of -$29882.4 and a median of -$146000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 34366.67% in 2022 and surged 1360.27% in 2024, its largest moves.
- Tracing KRYS's Interest & Investment Income over 5 years: stood at $747000.0 in 2022, then jumped by 45.38% to $1.1 million in 2023, then plunged by 206.17% to -$1.2 million in 2024, then surged by 82.57% to -$201000.0 in 2025, then tumbled by 684.58% to -$1.6 million in 2026.
- Business Quant data shows KRYS's Interest & Investment Income at -$1.6 million in Q1 2026, -$201000.0 in Q4 2025, and $657000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Krystal Biotech | 10.38 Bn | 9.56 Bn | 110.08 Mn | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.58 Mn |
| Dec 31, 2025 | -201,000.00 |
| Sep 30, 2025 | 657,000.00 |
| Jun 30, 2025 | -158,000.00 |
| Mar 31, 2025 | 344,000.00 |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | -252,000.00 |
| Mar 31, 2024 | -875,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -146,000.00 |
| Jun 30, 2023 | -82,000.00 |
| Mar 31, 2023 | 574,000.00 |
| Dec 31, 2022 | 747,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | -348,000.00 |
| Mar 31, 2022 | -1.03 Mn |
| Dec 31, 2021 | -149,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | -24,000.00 |